{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:49:12Z","timestamp":1775627352277,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although individuals with dementia have a high risk of developing seizures, whether seizures are associated with cholinesterase inhibitors, which are commonly prescribed to treat individuals with dementia, remains unknown. This study investigated the risk of incident seizure following cholinesterase inhibitor use in patients with dementia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A nationwide, nested case-control study was conducted using data from the Korean Health Insurance Review and Assessment Service (HIRA) from 2014 through 2018. A total of 13,767 participants aged 65\u201395\u00a0years who experienced incident seizure were propensity score-matched for medical comorbidities and drug exposure at a 1:3 ratio with a control group of 39,084 participants. The study examined the incidence of seizures in patients diagnosed with dementia within one year after receiving cognitive enhancers. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for seizure incidence according to cholinesterase inhibitor use were analyzed using a multivariable conditional logistic regression model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was no statistically significant association between duration of cholinesterase inhibitors use and seizure risk. Although there was slight increased seizure risk in patient after receiving donepezil for 1\u00a0year compared to memantine, subgroup analyses stratified age and sex did not reveal any significant association between cholinesterase inhibitors use and late-onset seizure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest no immediate increase in seizure risk is associated with cholinesterase inhibitor use, although the risk of seizure in patients with dementia did increase after one year of continued medication intake. Further study is required to obtain confirmatory results on the seizure-related safety of cognitive enhancers in patients with dementia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-022-03120-5","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T12:03:32Z","timestamp":1654257812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association of cognitive enhancers and incident seizure risk in dementia: a population-based study"],"prefix":"10.1186","volume":"22","author":[{"given":"Junghee","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nak-Hoon","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eosu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo","family":"Jung Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"3120_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.seizure.2019.06.016","volume":"71","author":"J Baker","year":"2019","unstructured":"Baker J, Libretto T, Henley W, Zeman A. The prevalence and clinical features of epileptic seizures in a memory clinic population. Seizure. 2019;71:83\u201392. https:\/\/doi.org\/10.1016\/j.seizure.2019.06.016.","journal-title":"Seizure"},{"issue":"11","key":"3120_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2165\/00002512-200320110-00001","volume":"20","author":"M Mendez","year":"2003","unstructured":"Mendez M, Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging. 2003;20(11):791\u2013803. https:\/\/doi.org\/10.2165\/00002512-200320110-00001.","journal-title":"Drugs Aging"},{"issue":"1","key":"3120_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/epd.2016.0808","volume":"18","author":"N Nicolas","year":"2016","unstructured":"Nicolas N, Fr\u00e9d\u00e9ric A, Margitta S. From here to epilepsy: the risk of seizure in patients with Alzheimer\u2019s disease. Epileptic Disord. 2016;18(1):1\u201312. https:\/\/doi.org\/10.1684\/epd.2016.0808.","journal-title":"Epileptic Disord"},{"issue":"6","key":"3120_CR4","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awy022","volume":"141","author":"A Sen","year":"2018","unstructured":"Sen A, Capelli V, Husain M. Cognition and dementia in older patients with epilepsy. Brain. 2018;141(6):1592\u2013608. https:\/\/doi.org\/10.1093\/brain\/awy022.","journal-title":"Brain"},{"issue":"8","key":"3120_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41582-021-00505-9","volume":"17","author":"M Romoli","year":"2021","unstructured":"Romoli M, Sen A, Parnetti L, Calabresi P, Costa C. Amyloid-\u03b2: a potential link between epilepsy and cognitive decline. Nat Rev Neurol. 2021;17(8):469\u201385. https:\/\/doi.org\/10.1038\/s41582-021-00505-9.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3120_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1684\/epd.2015.0739","volume":"17","author":"GL Holmes","year":"2015","unstructured":"Holmes GL. Cognitive impairment in epilepsy: the role of network abnormalities. Epileptic Disord. 2015;17(2):101\u201316. https:\/\/doi.org\/10.1684\/epd.2015.0739.","journal-title":"Epileptic Disord"},{"key":"3120_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainresbull.2020.04.009","volume":"160","author":"FS Giorgi","year":"2020","unstructured":"Giorgi FS, Saccaro LF, Busceti CL, Biagioni F, Fornai F. Epilepsy and Alzheimer\u2019s Disease: Potential mechanisms for an association. Brain Res Bull. 2020;160:107\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.04.009.","journal-title":"Brain Res Bull"},{"issue":"24","key":"3120_CR8","doi-asserted-by":"publisher","first-page":"e3241","DOI":"10.1212\/wnl.0000000000011077","volume":"95","author":"M Stefanidou","year":"2020","unstructured":"Stefanidou M, Beiser AS, Himali JJ, Peng TJ, Devinsky O, Seshadri S, et al. Bi-directional association between epilepsy and dementia: The Framingham Heart Study. Neurology. 2020;95(24):e3241\u20137. https:\/\/doi.org\/10.1212\/wnl.0000000000011077.","journal-title":"Neurology"},{"issue":"2","key":"3120_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.seizure.2009.11.005","volume":"19","author":"E Kumlien","year":"2010","unstructured":"Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure. 2010;19(2):69\u201373. https:\/\/doi.org\/10.1016\/j.seizure.2009.11.005.","journal-title":"Seizure"},{"issue":"7","key":"3120_CR10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1528-1167.2007.01114.x","volume":"48","author":"MJ Hamberger","year":"2007","unstructured":"Hamberger MJ, Palmese CA, Scarmeas N, Weintraub D, Choi H, Hirsch LJ. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy. Epilepsia. 2007;48(7):1283\u201391. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01114.x.","journal-title":"Epilepsia"},{"issue":"4","key":"3120_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/ebeh.2001.0221","volume":"2","author":"RS Fisher","year":"2001","unstructured":"Fisher RS, Bortz JJ, Blum DE, Duncan B, Burke H. A pilot study of donepezil for memory problems in epilepsy. Epilepsy Behav. 2001;2(4):330\u20134. https:\/\/doi.org\/10.1006\/ebeh.2001.0221.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"3120_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yebeh.2008.08.013","volume":"14","author":"P Mares","year":"2009","unstructured":"Mares P, Mikuleck\u00e1 A. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats. Epilepsy Behav. 2009;14(1):32\u20139. https:\/\/doi.org\/10.1016\/j.yebeh.2008.08.013.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"3120_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/0972-2327.179971","volume":"19","author":"P Marimuthu","year":"2016","unstructured":"Marimuthu P, Varadarajan S, Krishnan M, Shanmugam S, Kunjuraman G, Ravinder JR, et al. Evaluating the efficacy of memantine on improving cognitive functions in epileptic patients receiving anti-epileptic drugs: A double-blind placebo-controlled clinical trial (Phase IIIb pilot study). Ann Indian Acad Neurol. 2016;19(3):344\u201350. https:\/\/doi.org\/10.4103\/0972-2327.179971.","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"3120_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/026988110001400410","volume":"14","author":"NR Dunn","year":"2000","unstructured":"Dunn NR, Pearce GL, Shakir SA. Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol. 2000;14(4):406\u20138. https:\/\/doi.org\/10.1177\/026988110001400410.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"3120_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.yebeh.2008.05.006","volume":"13","author":"HR Griffith","year":"2008","unstructured":"Griffith HR, Martin R, Andrews S, LeBron PA, Ware J, Faught E, et al. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties. Epilepsy Behav. 2008;13(2):376\u201380. https:\/\/doi.org\/10.1016\/j.yebeh.2008.05.006.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"3120_CR16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","volume":"32","author":"JA Kim","year":"2017","unstructured":"Kim JA, Yoon S, Kim LY, Kim DS. Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data. J Korean Med Sci. 2017;32(5):718\u201328. https:\/\/doi.org\/10.3346\/jkms.2017.32.5.718.","journal-title":"J Korean Med Sci"},{"issue":"11","key":"3120_CR17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83.","journal-title":"Med Care"},{"issue":"5","key":"3120_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/ije\/29.5.891","volume":"29","author":"S Schneeweiss","year":"2000","unstructured":"Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000;29(5):891\u20138. https:\/\/doi.org\/10.1093\/ije\/29.5.891.","journal-title":"Int J Epidemiol"},{"issue":"15","key":"3120_CR19","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1212\/wnl.0000000000002023","volume":"85","author":"R Sutter","year":"2015","unstructured":"Sutter R, R\u00fcegg S, Tschudin-Sutter S. Seizures as adverse events of antibiotic drugs: A systematic review. Neurology. 2015;85(15):1332\u201341. https:\/\/doi.org\/10.1212\/wnl.0000000000002023.","journal-title":"Neurology"},{"issue":"9","key":"3120_CR20","doi-asserted-by":"publisher","first-page":"e1226","DOI":"10.4088\/JCP.16m11377","volume":"78","author":"CS Wu","year":"2017","unstructured":"Wu CS, Liu HY, Tsai HJ, Liu SK. Seizure Risk Associated With Antidepressant Treatment Among Patients With Depressive Disorders: A Population-Based Case-Crossover Study. J Clin Psychiatry. 2017;78(9):e1226\u201332. https:\/\/doi.org\/10.4088\/JCP.16m11377.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"3120_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011;46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786.","journal-title":"Multivariate Behav Res"},{"issue":"5","key":"3120_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","volume":"47","author":"JC Amatniek","year":"2006","unstructured":"Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, et al. Incidence and predictors of seizures in patients with Alzheimer\u2019s disease. Epilepsia. 2006;47(5):867\u201372. https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00554.x.","journal-title":"Epilepsia"},{"issue":"4","key":"3120_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1528-1157.1992.tb02343.x","volume":"33","author":"MJ McAreavey","year":"1992","unstructured":"McAreavey MJ, Ballinger BR, Fenton GW. Epileptic seizures in elderly patients with dementia. Epilepsia. 1992;33(4):657\u201360. https:\/\/doi.org\/10.1111\/j.1528-1157.1992.tb02343.x.","journal-title":"Epilepsia"},{"key":"3120_CR24","doi-asserted-by":"publisher","unstructured":"Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 1989;3(2):154\u201371. https:\/\/doi.org\/10.1002\/syn.890030207.","DOI":"10.1002\/syn.890030207"},{"issue":"7","key":"3120_CR25","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain\u202f: a journal of neurology. 2018;141(7):1917\u201333. https:\/\/doi.org\/10.1093\/brain\/awy132.","journal-title":"Brain : a journal of neurology"},{"issue":"11","key":"3120_CR26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/hipo.20471","volume":"18","author":"LA Craig","year":"2008","unstructured":"Craig LA, Hong NS, Kopp J, McDonald RJ. Reduced cholinergic status in hippocampus produces spatial memory deficits when combined with kainic acid induced seizures. Hippocampus. 2008;18(11):1112\u201321. https:\/\/doi.org\/10.1002\/hipo.20471.","journal-title":"Hippocampus"},{"issue":"1","key":"3120_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1471-4159.1997.68010313.x","volume":"68","author":"M Serra","year":"1997","unstructured":"Serra M, Dazzi L, Cagetti E, Chessa MF, Pisu MG, Sanna A, et al. Effect of pentylenetetrazole-induced kindling on acetylcholine release in the hippocampus of freely moving rats. J Neurochem. 1997;68(1):313\u20138. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.68010313.x.","journal-title":"J Neurochem"},{"key":"3120_CR28","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez de Sevilla D, N\u00fa\u00f1ez A, Borde M, Malinow R, Bu\u00f1o W. Cholinergic-mediated IP3-receptor activation induces long-lasting synaptic enhancement in CA1 pyramidal neurons. J Neurosci. 2008;28(6):1469\u201378. https:\/\/doi.org\/10.1523\/jneurosci.2723-07.2008.","DOI":"10.1523\/jneurosci.2723-07.2008"},{"issue":"3","key":"3120_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/jnnp.66.3.410","volume":"66","author":"T Babic","year":"1999","unstructured":"Babic T, Zurak N. Convulsions induced by donepezil. J Neurol Neurosurg Psychiatry. 1999;66(3):410. https:\/\/doi.org\/10.1136\/jnnp.66.3.410.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"3120_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.22159\/ijpps.2017v9i7.19057","volume":"9","author":"J Shareef","year":"2017","unstructured":"Shareef J, Joseph J, Adithi K. A single case report on hyponatremia seizure induced by acetylcholinesterase inhibitors. Int J Pharm Pharm Sci. 2017;9(7):165\u2013216. https:\/\/doi.org\/10.22159\/ijpps.2017v9i7.19057.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"9","key":"3120_CR31","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/106002809202600914","volume":"26","author":"NR Cutler","year":"1992","unstructured":"Cutler NR, Sramek JJ, Murphy MF, Nash RJ. Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer\u2019s disease. Ann Pharmacother. 1992;26(9):1118\u201322.","journal-title":"Ann Pharmacother"},{"issue":"9011","key":"3120_CR32","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(96)90992-7","volume":"347","author":"F Lebert","year":"1996","unstructured":"Lebert F, Hasenbroekx C, Pasquier F, Petit H. Convulsive effects of tacrine. Lancet (London, England). 1996;347(9011):1339\u201340.","journal-title":"Lancet (London, England)"},{"issue":"11","key":"3120_CR33","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3390\/ijms18112311","volume":"18","author":"JH Jeong","year":"2017","unstructured":"Jeong JH, Choi BY, Kho AR, Lee SH, Hong DK, Lee SH, et al. Diverse Effects of an Acetylcholinesterase Inhibitor, Donepezil, on Hippocampal Neuronal Death after Pilocarpine-Induced Seizure. Int J Mol Sci. 2017;18(11):2311. https:\/\/doi.org\/10.3390\/ijms18112311.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3120_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000106895","volume":"7","author":"SL Rogers","year":"1996","unstructured":"Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer\u2019s disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group Dementia. 1996;7(6):293\u2013303. https:\/\/doi.org\/10.1159\/000106895.","journal-title":"The Donepezil Study Group Dementia"},{"key":"3120_CR35","doi-asserted-by":"publisher","unstructured":"Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology. 1998;51(1 Suppl 1):S2\u201317; discussion S65\u20137. https:\/\/doi.org\/10.1212\/wnl.51.1_suppl_1.s2.","DOI":"10.1212\/wnl.51.1_suppl_1.s2"},{"issue":"1","key":"3120_CR36","first-page":"76","volume":"33","author":"JK Park","year":"2000","unstructured":"Park JK, Kim KS, Lee TY, Lee KS, Lee DH, Lee SH, et al. The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims. J Prev Med Public Health. 2000;33(1):76\u201382.","journal-title":"J Prev Med Public Health"},{"issue":"1","key":"3120_CR37","doi-asserted-by":"publisher","first-page":"24069","DOI":"10.1038\/s41598-021-03406-5","volume":"11","author":"J Ha","year":"2021","unstructured":"Ha J, Choi D-W, Kim KJ, Cho SY, Kim H, Kim KY, et al. Association of metformin use with Alzheimer\u2019s disease in patients with newly diagnosed type 2 diabetes: a population-based nested case-control study. Sci Rep. 2021;11(1):24069. https:\/\/doi.org\/10.1038\/s41598-021-03406-5.","journal-title":"Sci Rep"},{"key":"3120_CR38","doi-asserted-by":"publisher","unstructured":"Lyou HJ, Seo K-D, Lee JE, Pak HY, Lee JH. Association of Alzheimer\u2019s Disease with the Risk of Developing Epilepsy: a 10-Year Nationwide Cohort Study. Dement Neurocogn Disord. 2018;17(4):156\u201362.\u00a0https:\/\/doi.org\/10.12779\/dnd.2018.17.4.156.","DOI":"10.12779\/dnd.2018.17.4.156"},{"key":"3120_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2020.106462","volume":"167","author":"GK Mbizvo","year":"2020","unstructured":"Mbizvo GK, Schnier C, Simpson CR, Duncan SE, Chin RFM. Validating the accuracy of administrative healthcare data identifying epilepsy in deceased adults: A Scottish data linkage study. Epilepsy Res. 2020;167: 106462. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106462.","journal-title":"Epilepsy Res"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-022-03120-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T12:06:13Z","timestamp":1654257973000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-022-03120-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1186\/s12877-022-03120-5","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"22 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Yongin Severance Hospital (No. 9\u20132020\u20130001), and the approving authority waived the requirement for informed consent because of deidentified patient data. All methods were carried out in accordance with relevant guidelines and regulations (declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"480"}}